To kick off mock draft season, I decided to use mock drafts as a way to start our look at potential draft targets for the ...

Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after prior targeted treatment.

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

Medications targeting the neonatal fragment crystallizable receptor have gained attention due to multiple recent FDA ...

Detailed price information for Corvus Pharma Com (CRVS-Q) from The Globe and Mail including charting and trades.

Moderna (NASDAQ:MRNA) executives highlighted progress on cost reductions, a ramp in international partnerships, and multiple late-stage pipeline milestones during the company’s fourth-quarter 2025 ...

Thank you, Kevin. Good morning, everyone, and thank you for joining us on today’s call to discuss Moderna, Inc.’s fourth quarter 2025 financial results and business update. On today’s call are ...

Ginger and peppermint can help ease nausea, but ginger is often more effective due to compounds such as gingerols and shogaols.

H&R Block's DIY tax-filing platform uses a straightforward interface that prompts users with questions to determine which plan is right and if they're eligible for various deductions. If you have ...

Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the ...